CTT Pharmaceutical Holdings, Inc. (CTTH) stock
CTTHOTCPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2015, quý kết thúc ngày Sep 30, 2015Last filing: 10-Q on Nov 18, 2026
$0.06−0.00 (-0.17%)
Close on Oct 16, 2026Market cap $1.26MP/E –Yield –
CTT Pharmaceutical r&d expenses
Research and development expenses are spending on new products and technology.
No r&d expenses figures for CTT Pharmaceutical
CTT Pharmaceutical has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?